Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2016

Jul 25, 2016

30681_dirs_2016-07-25_083d227b-c9a5-455a-be4a-b3c690e3f8d5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-07-21

Reporting Person: ENRIGHT PATRICK G (Director, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-07-21 Stock Option (Right to Buy) $5.86 A 30000 Acquired 2026-07-21 Common Stock (30000) Direct

Footnotes

F1: The vesting period of the shares underlying the option award commenced on June 27, 2016, with 8.3334% of the shares to vest on each monthly anniversary of the grant date until all shares are vested. The reporting person shares pecuniary interest in these securities with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership of these securities except as to the extent of the reporting person's pecuniary interest in these securities.